Nmj Disruption
Nmj Disruption - Related Videos
06:42
Drosophila Larval NMJ Dissection
0 Views •
Cited by 115 •
2009
This protocol demonstrates how to dissect Drosophila larvae in preparation for immunohistochemistry and/or imaging of the neuromuscular junction.
05:08
Drosophila Neuromuscular Junction (NMJ) Quantification: A Method to Assess Synaptic Morphology and Function
0 Views •
2023
The Drosophila neuromuscular junction (NMJ) is used as a model to study the morphology and function of synapses. This video describes important features that researchers quantify to characterize the NMJ. The example protocol demonstrates a software able to perform the quantification automatically.
05:46
Electrophysiological Methods for Recording Synaptic Potentials from the NMJ of Drosophila Larvae
0 Views •
Cited by 29 •
2009
Here we describe electrophysiological methods for measuring synaptic transmission at the neuromuscular junction of Drosophila larva. Evoked release is initiated artificially by stimulating the motor neuron axons, and transmission through the NMJ can be measured by the postsynaptic response evoked in the muscle.
11:56
Historical View and Physiology Demonstration at the NMJ of the Crayfish Opener Muscle
0 Views •
Cited by 33 •
2009
The opener muscle of the crayfish leg is presented for its historical importance and experimental versatility in muscle phenotype, synaptic physiology and plasticity.
10:10
Drosophila Larval NMJ Immunohistochemistry
0 Views •
Cited by 26 •
2009
This protocol demonstrates how to perform immunohistochemistry on dissected Drosophila larva.
FAQs
Altered acetylcholine release weakens the first chemical step in neuromuscular signaling. A motor-neuron action potential may fail to produce an adequate transmitter signal at the nerve terminal, so less activation reaches nicotinic receptors on the muscle membrane. The resulting end-plate response may be insufficient to support effective skeletal-muscle contraction.
Nicotinic receptor dysfunction prevents acetylcholine from producing a normal response in the muscle membrane, even when transmitter release occurs. Because these receptors help generate the end-plate potential, their impaired activity interrupts the electrical drive needed for contraction. This distinguishes a postsynaptic problem from disruption originating at the presynaptic nerve terminal.
NMJ disruption can arise at different biological sites. Structural damage can compromise the junction itself, autoimmune attack can target components of transmission, and neurotoxins can interfere with signaling. These mechanisms share a failure of communication but may affect different parts of the process, making the underlying cause important when interpreting weakness or fatigability.
Within neuroscience, this topic links cellular synaptic transmission to whole-muscle function. It provides a framework for examining how changes at a specialized nerve-muscle connection can produce weakness and fatigability. The same framework supports investigation of communication failure across myasthenia gravis, motor neuron diseases, and inherited neuromuscular disorders.
NMJ disruption offers a common functional context for comparing diseases that impair neuromuscular communication. In myasthenia gravis, motor neuron diseases, and inherited neuromuscular disorders, researchers can relate muscle impairment to altered release, receptor dysfunction, structural damage, autoimmune attack, or neurotoxins. This comparison helps organize disease mechanisms without assuming that every disorder affects the junction identically.
Therapeutic work can focus on restoring synaptic transmission or preserving muscle function, the two outcomes highlighted by this biological model. Identifying whether disruption affects neurotransmitter release, nicotinic receptors, or junctional structure helps define what must be protected or recovered. The approach therefore connects mechanistic neuroscience with strategies for reducing functional impairment.